These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor. Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722 [TBL] [Abstract][Full Text] [Related]
25. SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M Chopko TC; Han C; Gregro AR; Engers DW; Felts AS; Poslusney MS; Bollinger KA; Morrison RD; Bubser M; Lamsal A; Luscombe VB; Cho HP; Schnetz-Boutaud NC; Rodriguez AL; Chang S; Daniels JS; Stec DF; Niswender CM; Jones CK; Wood MR; Wood MW; Duggan ME; Brandon NJ; Conn PJ; Bridges TM; Lindsley CW; Melancon BJ Bioorg Med Chem Lett; 2019 Aug; 29(16):2224-2228. PubMed ID: 31248774 [TBL] [Abstract][Full Text] [Related]
26. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists. Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442 [TBL] [Abstract][Full Text] [Related]
27. Antinociceptive effects of potent, selective and brain penetrant muscarinic M Grauer SM; Sanoja R; Poulin D; Rashid H; Jochnowitz N; Calhoun M; Zwilling D; Varty GB; Rosahl TW; Meziane H; Mittlelhaeuser C; Mazzola R; Morrow J; Smith SM; Henze D; Marcus J Brain Res; 2020 Jun; 1737():146814. PubMed ID: 32234514 [TBL] [Abstract][Full Text] [Related]
28. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors. Lanzafame AA; Sexton PM; Christopoulos A Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648 [TBL] [Abstract][Full Text] [Related]
29. Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity. Marlo JE; Niswender CM; Days EL; Bridges TM; Xiang Y; Rodriguez AL; Shirey JK; Brady AE; Nalywajko T; Luo Q; Austin CA; Williams MB; Kim K; Williams R; Orton D; Brown HA; Lindsley CW; Weaver CD; Conn PJ Mol Pharmacol; 2009 Mar; 75(3):577-88. PubMed ID: 19047481 [TBL] [Abstract][Full Text] [Related]
30. Probing the binding site of novel selective positive allosteric modulators at the M Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683 [TBL] [Abstract][Full Text] [Related]
31. Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators. Kuduk SD; Di Marco CN; Saffold JR; Ray WJ; Ma L; Wittmann M; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Beshore DC Bioorg Med Chem Lett; 2014 Mar; 24(5):1417-20. PubMed ID: 24485781 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptor. Kennedy JP; Bridges TM; Gentry PR; Brogan JT; Kane AS; Jones CK; Brady AE; Shirey JK; Conn PJ; Lindsley CW ChemMedChem; 2009 Oct; 4(10):1600-7. PubMed ID: 19705385 [No Abstract] [Full Text] [Related]
33. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects. Valant C; Felder CC; Sexton PM; Christopoulos A Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256 [TBL] [Abstract][Full Text] [Related]
34. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Jakubík J; Bacáková L; El-Fakahany EE; Tucek S Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827 [TBL] [Abstract][Full Text] [Related]
35. Discovery and structure-activity relationships study of positive allosteric modulators of the M Tanaka H; Negoro K; Koike T; Tsukamoto I; Yokoyama K; Maeda J; Inagaki Y; Shimoshige Y; Ino K; Ishizu K; Takahashi T Bioorg Med Chem; 2020 Jul; 28(13):115531. PubMed ID: 32386953 [TBL] [Abstract][Full Text] [Related]
36. Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor. Flohr A; Hutter R; Mueller B; Bohnert C; Pellisson M; Schaffhauser H Bioorg Med Chem Lett; 2017 Dec; 27(24):5415-5419. PubMed ID: 29146472 [TBL] [Abstract][Full Text] [Related]
37. Discovery of a novel, CNS penetrant M Bewley BR; Spearing PK; Weiner RL; Luscombe VB; Zhan X; Chang S; Cho HP; Rodriguez AL; Niswender CM; Conn PJ; Bridges TM; Engers DW; Lindsley CW Bioorg Med Chem Lett; 2017 Sep; 27(18):4274-4279. PubMed ID: 28866269 [TBL] [Abstract][Full Text] [Related]
38. Discovery of [ Tong L; Li W; Lo MM; Gao X; Wai JM; Rudd M; Tellers D; Joshi A; Zeng Z; Miller P; Salinas C; Riffel K; Haley H; Purcell M; Holahan M; Gantert L; Schubert JW; Jones K; Mulhearn J; Egbertson M; Meng Z; Hanney B; Gomez R; Harrison ST; McQuade P; Bueters T; Uslaner J; Morrow J; Thomson F; Kong J; Liao J; Selyutin O; Bao J; Hastings NB; Agrawal S; Magliaro BC; Monsma FJ; Smith MD; Risso S; Hesk D; Hostetler E; Mazzola R J Med Chem; 2020 Mar; 63(5):2411-2425. PubMed ID: 32101422 [TBL] [Abstract][Full Text] [Related]